Best Support Care (BSC)
Showing 1 - 25 of >10,000
Gastric Adenocarcinoma, Pancreatic Cancer, Gastroesophageal Junction Adenocarcinoma Trial in China (CT041 autologous CAR T-cell
Recruiting
- Gastric Adenocarcinoma
- +2 more
- CT041 autologous CAR T-cell injection
- Physician's Choice(Paclitaxel or Irinotecan or Apatinib or Anti-PD-1 antibody)
-
Hefei, Anhui, China
- +9 more
Feb 13, 2022
MDS Trial in Worldwide (Oral Azacitidine, Placebo for Oral Azacitidine)
Not yet recruiting
- Myelodysplastic Syndromes
- Oral Azacitidine
- Placebo for Oral Azacitidine
-
Buenos Aires, Argentina
- +1 more
Aug 1, 2022
Advanced Lung Carcinoma, Stage III Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8 Trial in Jacksonville (Best Practice,
Recruiting
- Advanced Lung Carcinoma
- +2 more
- Best Practice
- +3 more
-
Jacksonville, FloridaMayo Clinic in Florida
Dec 6, 2022
COVID-19, Infections, Morality Trial in Fuzhou (Medical observation, Supportive treatment (BSC), Intensive care management)
Recruiting
- COVID-19
- +3 more
- Medical observation
- +2 more
-
Fuzhou, Fujian, ChinaThe 900th Hospital of the Joint Logistic Support Force, PLA
Jan 7, 2023
Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial in Houston (Best Practice, Educational Intervention,
Recruiting
- Metastatic Malignant Solid Neoplasm
- Recurrent Malignant Solid Neoplasm
- Best Practice
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 11, 2022
Mast Cell Activation Syndrome Trial in Weldon Spring, Toulouse (Masitinib 4.5 mg/kg/day, Placebo, Best supportive care)
Recruiting
- Mast Cell Activation Syndrome
- Masitinib 4.5 mg/kg/day
- +3 more
-
Weldon Spring, Missouri
- +1 more
Jul 18, 2022
Platinum-sensitive Ovarian Cancer, Relapsed Ovarian Cancer Trial in France (OSE2101, Pembrolizumab 25 MG/ML [Keytruda])
Recruiting
- Platinum-sensitive Ovarian Cancer
- Relapsed Ovarian Cancer
- OSE2101
- Pembrolizumab 25 MG/ML [Keytruda]
-
Angers, France
- +27 more
Jul 25, 2022
Carcinoma, Hepatocellular Trial in Worldwide (biological, drug, other)
Active, not recruiting
- Carcinoma, Hepatocellular
- pembrolizumab
- +2 more
-
Hefei, Anhui, China
- +40 more
Mar 3, 2022
Metastatic Prostate Carcinoma, Stage III Prostate Cancer AJCC v8, Stage IV Prostate Cancer AJCC v8 Trial (Patient Navigation,
Not yet recruiting
- Metastatic Prostate Carcinoma
- +2 more
- Patient Navigation
- +3 more
- (no location specified)
Aug 2, 2022
Urothelial Cancer Trial in Worldwide (Avelumab, Best Supportive Care, Following the planned interim analysis for this study:
Active, not recruiting
- Urothelial Cancer
- Avelumab
- +2 more
-
Aurora, Colorado
- +370 more
Oct 24, 2022
Colorectal Carcinoma Trial in Los Angeles (Best Practice, Consultation, Educational Intervention)
Recruiting
- Colorectal Carcinoma
- Best Practice
- +8 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Oct 13, 2023
Palliative Care, Kidney Failure, Chronic, Decision Making Trial in United States (Best Case/Worst Case communication tool
Enrolling by invitation
- Palliative Care
- +13 more
- Best Case/Worst Case communication tool training
-
Denver, Colorado
- +9 more
Jul 21, 2022
Acute Myeloid Leukemia (AML), Cancer Trial in Worldwide (Venetoclax, Azacitidine, Best Supportive Care (BSC))
Recruiting
- Acute Myeloid Leukemia (AML)
- Cancer
- Venetoclax
- +2 more
-
Scottsdale, Arizona
- +169 more
Aug 23, 2022
Ovarian Cancer, Fallopian Tube Adenocarcinoma, Fallopian Tube Carcinosarcoma Trial in Seattle (Exercise Counseling, Aerobic
Terminated
- Ovarian Cancer
- +21 more
- Exercise Counseling
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 6, 2022
Anemia Trial in Worldwide (biological, drug, other)
Recruiting
- Anemia
- Luspatercept
- +2 more
-
Halifax, Nova Scotia, Canada
- +11 more
Jan 3, 2023
Nasopharyngeal Carcinoma Trial in Guangzhou (capecitabine, Best supportive care (BSC))
Completed
- Nasopharyngeal Carcinoma
- capecitabine
- Best supportive care (BSC)
-
Guangzhou, Guangdong, ChinaSunYat-senU
Jul 30, 2020
Thalassemia Trial in Worldwide (Luspatercept, Placebo, Best Supportive Care (BSC))
Active, not recruiting
- Thalassemia
- Luspatercept
- +2 more
-
Los Angeles, California
- +16 more
Aug 16, 2022
Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker
Active, not recruiting
- Acute Myeloid Leukemia
- +66 more
- Best Practice
- +3 more
-
Fullerton, CaliforniaVirginia K Crosson Cancer Center
Jan 31, 2022
Thrombotic Microangiopathy Trial in Worldwide (Ravulizumab, Placebo, Best supportive care)
Recruiting
- Thrombotic Microangiopathy
- Ravulizumab
- +2 more
-
Tampa, Florida
- +90 more
Jan 26, 2023
Indolent Systemic Mastocytosis, Monoclonal Mast Cell Activation Syndrome Trial in Worldwide (BLU-263, Placebo)
Recruiting
- Indolent Systemic Mastocytosis
- Monoclonal Mast Cell Activation Syndrome
- BLU-263
- Placebo
-
Palo Alto, California
- +33 more
Jul 27, 2022
Feasibility of Best Supportive Care Delivery Trial (Best Supportive Care Checklist)
Completed
- Feasibility of Best Supportive Care Delivery
- Best Supportive Care Checklist
- (no location specified)
Feb 27, 2020